COVID has affected 60% of Americans, natural gas prices are skyrocketing: 5 things podcast

From today’s episode of the 5 Things podcast: A new era of diagnostics for Alzheimer’s disease

Health reporter Ken Alltucker explains. Additionally, Russia is opening a new front in its fight for Ukraine, nearly 60% of Americans have been infected with COVID-19, financial journalist Bailey Schulz talks about rising natural gas prices, and a panel of the House holds a hearing on the ethical requirements of the Supreme Court.

Podcast :True crime, in-depth interviews and more USA TODAY podcasts here.

Hit play on the player above to listen to the podcast and follow the transcript below. This transcript was auto-generated and then edited for clarity in its current form. There may be differences between audio and text.

Taylor Wilson:

Hello. I’m Taylor Wilson and here are 5 things you need to know Wednesday, April 27, 2022. Today, a new era for Alzheimer’s diagnosis, plus Russia’s final front in the fight for Ukraine and more Again.

Here are some of the main titles:

  1. A Myanmar court has found the country’s former leader, Aung San Suu Kyi, guilty of corruption and sentenced her to five years in prison. It is the first of several corruption cases against her in the military-ruled country. It was ousted by an army takeover last year.
  2. Earlier in the day, Israeli forces shot dead an 18-year-old Palestinian man and injured three others during clashes in the occupied West Bank. A 16-year-old boy was also shot and injured.
  3. And the funeral will be today for Madeline Albright. America’s first female secretary of state died of cancer last month at the age of 84.

We may be entering a new era in the diagnosis of Alzheimer’s disease. More than half a dozen blood tests are being developed and tested to detect signs of neurodegenerative disease in elderly patients. Health journalist Ken Alltucker has more.

Ken Alltucker:

There has been a great deal of interest in Alzheimer’s disease research for about two decades. Drugmakers have been trying to find a drug or treatment that could slow down the disease, which causes memory and thinking problems primarily in older people. What the researchers are trying to do is come up with a blood test that could somehow detect this protein in your blood, rather than having to go through that extra step of a spinal tap or brain scan. And there’s a test on the market that’s been available since 2020. It’s mostly used for research right now, because when researchers do these big clinical trials to try to find a cure for Alzheimer’s disease, they have to screen hundreds, thousands of people. so that the right people enroll in the study. So that’s mostly how it’s used, but some doctors are starting to use this particular blood test.

USA Today

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button